The ATOMIC-Meso trial is investigating the use of a new drug called ADI-PEG 20 used in conjunction with chemotherapy. This trial is open to patients with pleural mesothelioma with unresectable disease. ATOMIC-Meso is now closed.
The ATOMIC-Meso trial is investigating the use of a new drug called ADI-PEG 20 used in conjunction with chemotherapy. This trial is open to patients with pleural mesothelioma with unresectable disease. ATOMIC-Meso is now closed.